MedPath
HSA Approval

OLANKLINE TABLETS 5MG

SIN14124P

OLANKLINE TABLETS 5MG

OLANKLINE TABLETS 5MG

March 20, 2012

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

N05AH03

olanzapine

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

DR REDDY'S LABORATORIES LIMITED

Active Ingredients

OLANZAPINE

5.0 MG

Olanzapine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

OLANKLINE TABLETS 5MG - HSA Approval | MedPath